Early experience with targeted and combination biopsies in prostate cancer work-up in Denmark from 2012 to 2016
World Journal of Urology · 2024
DOI: 10.1007/s00345-024-05234-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2024. Verfasst von Anna Arendt Blak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Prostate Cancer Center, Department of Urology, Copenhagen University Hospital - Rigshospitalet, Ole Maaløes Vej 24, Copenhagen, 7521. 2200…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Neoplasm Grading. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Hospital.
Abstract (Originalsprache)
Purpose
To investigate the early implementation of combined systematic and targeted (cBx) primary biopsy in prostate cancer diagnosis and define the concordance in Gleason grading (GG) of different biopsy techniques with radical prostatectomy (RP) pathology.
Methods
This population-based analysis includes data on all men in Denmark who underwent primary cBx or standalone systematic (sBx) prostate biopsy between 2012 and 2016. Biopsy results were compared to RP pathology if performed within a year. Concordance measurement was estimated using Cohen’s Kappa, and the cumulative incidence of cancer-specific death was estimated at 6 years with the Aalen-Johansen estimator.
Results
Concordance between biopsy and RP pathology was 0.53 (95CI: 0.43–0.63), 0.38 (95CI: 0.29–0.48), and 0.16 (95CI: 0.11–0.21) for cBx, targeted biopsy (tBx), and sBx, respectively. For standalone sBx and RP, concordance was 0.29 (95CI: 0.27–0.32). Interrelated GG concordance between tBx and sBx was 0.67 (95CI: 0.62–0.71) in cBx. The proportion of correctly assessed GG based on RP pathology was 54% in both cBx and standalone sBx. Incidence of prostate cancer-specific death was 0% regardless of biopsy technique in GG 1, and 22% (95CI: 11–32), 30% (95CI: 15–44), and 19% (95CI: 7.0–30) in GG 5 for cBx, tBx, or sBx, respectively.
Conclusion
Overall, the cBx strategy demonstrates higher concordance to RP pathology than the standalone sBx. However, cBx exhibits more overgrading of the GG of RP pathology compared to sBx. Ultimately, the classic grading system does not take change in the diagnostic pathway into account, and grading should be altered accordingly to ensure appropriate treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Copenhagen Prostate Cancer Center, Department of Urology, Copenhagen University Hospital - Rigshospitalet, Ole Maaløes Vej 24, Copenhagen, 7521. 2200, Denmark. anna.arendt.blak.01@regionh.dk.
- Copenhagen Prostate Cancer Center, Department of Urology, Copenhagen University Hospital - Rigshospitalet, Ole Maaløes Vej 24, Copenhagen, 7521. 2200, Denmark.
- Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Förderung
- National Hospital
Zitieren
APA
Blak, A. A., Stroomberg, H. V., Brasso, K., Larsen, S. B., & Røder, A. (2024). Early experience with targeted and combination biopsies in prostate cancer work-up in Denmark from 2012 to 2016. World Journal of Urology. https://doi.org/10.1007/s00345-024-05234-4
Vancouver
Blak AA, Stroomberg HV, Brasso K, Larsen SB, Røder A. Early experience with targeted and combination biopsies in prostate cancer work-up in Denmark from 2012 to 2016. World Journal of Urology. 2024. doi:10.1007/s00345-024-05234-4
BibTeX
@article{Blak2024,
author = {Blak, Anna Arendt and Stroomberg, Hein V and Brasso, Klaus and Larsen, Signe Benzon and Røder, Andreas},
title = {Early experience with targeted and combination biopsies in prostate cancer work-up in Denmark from 2012 to 2016},
journal = {World Journal of Urology},
year = {2024},
doi = {10.1007/s00345-024-05234-4}
}
EUVIMED